PERSONAL PROTECTION EQUIPMENT AND SARS-CoV-2 CONTAMINATION
1 other identifier
observational
49
1 country
1
Brief Summary
Transmission of SARS-CoV-2 occurs through common routes, aerosols and medical procedure. Personal protective equipment (PPE) reduces the risk of contamination. The risk of contamination of skin and clothing may be particularly high during removal PPE. The Ministry of Health (MOH) of Israel adapted the technique of using a supervisor that monitors during removal of the PPE. The aim of this study to examine the using the pre-established protocol, where a staff member removing the PPE according supervision by a staff monitor in comparison with removing the PPE without being instructed neither supervised. The Protocol provided by MOH is in accordance with the recommendations of the Centers for Disease Control United States (CDC), was presented to all staff. Study population will include 49 participants: 7 nurses, 7 clinician physicians, 7 cleaning personal, 7 X-rays technicians, 7 anesthesia technician and 7 physiotherapists 7 stretcher bearers, will performed this quality control observational study. The trail processes of doffing the PPE will be performed twice, first in the present of a trained supervisor and verbal instructions and once again independently in the absence of supervision. After donning the routine uniform with a new PPE, then the subject will be asked to transfer to an area were the participant's' PPE will be "contaminated" (in the same areas in all participants: over the thorax, shoulders, arms, hands legs and Face Shield) using a brush tool, with the 'Glo' Germ Solution that simulates contamination with a virus on the PPE. The 'Glo' Germ Solution is a non toxic, odorless gel, which glows brightly in the dark when exposed to ultraviolet light to simulate contamination with the virus. To proceed, the participant will be asked to move a step aside to another area. There the participant will remove the PPE. After the removal of the PPE the participant will be examined in a dark plot in order to detect a probably contamination traces with the 'Glo' Germ solution that will be illuminated under the ultraviolet UV light. The participant will repeat the procedure from the beginning, following all stages only in this second time without following the supervisor verbal instructions. In both trails, after the PPE removal, Ultraviolet Lamp will be used in order to check if the participant had been contaminated in any part of the body or cloth with the 'Glo' Germ Solution
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 15, 2021
CompletedFirst Submitted
Initial submission to the registry
August 15, 2021
CompletedFirst Posted
Study publicly available on registry
August 17, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedApril 27, 2022
April 1, 2022
6 months
August 15, 2021
April 20, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Contamination with simulated virus
Quality control observation
15 minutes
Study Arms (2)
Doffing PPE with verbal instructions and monitor
The subject will remove the PPE according to verbal instructions by a monitor
Doffing PPE without verbal instructions
The subject will remove the PPE independently without a monitor
Eligibility Criteria
Staff members of the CORONA UNIT
You may qualify if:
- Age limit
- Staff members who worked in CORONA UNIT
You may not qualify if:
- Staff members who did not work in CORONA UNIT
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bnai Zion Medical Center
Haifa, Israel
Study Officials
- STUDY DIRECTOR
Mostafa Somri, MD
Bnai Zion Medical Center
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Clinical Professor of Anesthesiology
Study Record Dates
First Submitted
August 15, 2021
First Posted
August 17, 2021
Study Start
July 15, 2021
Primary Completion
December 31, 2021
Study Completion
December 31, 2021
Last Updated
April 27, 2022
Record last verified: 2022-04